NR1H4 and obesity due to melanocortin 4 receptor deficiency: These findings demonstrated that Gly-MCA has beneficial effects on obesity through the modulation of the gut microbiota and intestinal FXR signaling and could be developed as a new drug to treat fatty liver disease.